Search company, investor...
Ketamine Media company logo

Ketamine Media

ketaminemedia.com

Founded Year

2016

Stage

Acquired | Alive

About Ketamine Media

Ketamine Media operates as a marketing agency working in the ketamine and psychedelic wellness space. The company helps in raising awareness about the clinical use of Ketamine. It provides Ketamine providers with inbound marketing, marketing automation, search engine optimization, content marketing, and more. It was founded in 2016 and is based in Knoxville, Tennessee.

Headquarters Location

611 King St NW Suite 200B

Knoxville, Tennessee, 37917,

United States

+1-800-975-2291

Missing: Ketamine Media's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Ketamine Media's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Ketamine Media

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Ketamine Media is included in 1 Expert Collection, including Psychedelics.

P

Psychedelics

329 items

Latest Ketamine Media News

Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More

Mar 27, 2023

––% Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More March 27, 2023 6:39 PM | 4 min read Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses Enveric Biosciences ENVB has created an Australia-based subsidiary , Enveric Therapeutics, to support its next-generation psychedelics program for anxiety disorders. FSD Pharma Inc.'s HUGE Australian business, FSD Pharma Australia, has been approved by the Alfred Ethics Committee to begin a Phase 1 clinical trial of next-gen drug candidate Lucid-201 for cases of Major Depressive Disorder. Emyria Ltd. is working with the University of Western Australia to expand its MDMA analogs library. Study Sheds Light On How A Brain On Ayahuasca Looks A new study, led by a group at Imperial College London, revealed the most advanced-to-date brain images of the effects of the psychedelic compound DMT. The trial monitored the brain activity of 20 healthy volunteers receiving either a 20mg DMT injection or a placebo through functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) before, during and after the psychedelic session. The brain’s normal structures change their standard hierarchical modes towards a more fluid communication and connectivity between regions related to imagination, language, memory and other higher-level functions. The Latest Moves On States With Reform Bills The Psychedelic Medicine Political Action Committee (PAC) is the latest activist-formed organization focused on steering federal funding toward research, education and ultimately encouraging policymakers on both sides of the aisle to revise long-standing restrictions on these substances. With the goal of raising $10 million in its first year, the new group is petitioning donors, including investors in the for-profit biotech space. At the state level, this week’s highlights occurred in California, Missouri, Hawaii, Texas, Minnesota, Vermont, Nevada, Washington and New Hampshire. The Milestone Round Each week, Benzinga learns about new clinical trials, compounds and potential treatments: Lucy Scientific DOSEF agreed to buy Wesana Health Holdings Inc.'s WSNAF psilocybin and CBD therapy; it also launched a new brand of products containing Amanita Muscaria mushrooms with partner High Times. Irwin Naturals IWINF purchased Keta Media LLC. Field Trip Health & Wellness requested creditor protection . The concern is whether it will be able to re-emerge from it. Psycheceutical Bioscience BWVI’s published data supports the potential of its ketamine topical cream for treating PTSD. New York-based ketamine therapy center Nushama exclusively shared its healthcare practices and co-founder Jay Godfrey provided further detail on prices, insurance, competition and the company’s expansion plans. A small review on Salvador Dali’s psychedelic -inspired artworks. Meet some of the biggest names in the psychedelics VCs and EFTs scenario at the second edition of our Psychedelics Capital Conference at the Fontainebleau Miami Beach Hotel on April 13!

Ketamine Media Frequently Asked Questions (FAQ)

  • When was Ketamine Media founded?

    Ketamine Media was founded in 2016.

  • Where is Ketamine Media's headquarters?

    Ketamine Media's headquarters is located at 611 King St NW, Knoxville.

  • What is Ketamine Media's latest funding round?

    Ketamine Media's latest funding round is Acquired.

  • Who are the investors of Ketamine Media?

    Investors of Ketamine Media include Irwin Naturals.

  • Who are Ketamine Media's competitors?

    Competitors of Ketamine Media include Ketamine Wellness Centers and 4 more.

Compare Ketamine Media to Competitors

Mindbloom Logo
Mindbloom

Mindbloom provides a platform that helps licensed psychiatric clinicians to achieve better outcomes for their patients with lower costs and greater convenience. The company provides science-backed mental health research and provides health and well-being treatments specifically through ketamine therapy for depression and anxiety.

NUE Life Health Logo
NUE Life Health

NUE Life Health is a telemedicine startup that develops a mental wellness solution employing treatments such as psychedelic-assisted therapies, combined with a graph database-driven app. NUE Life Health was founded in 2020 and is based in Miami Beach, Florida.

Wependio Logo
Wependio

Wependio is a social network for travelers that helps them to share their memories and journeys with others. It helps users find and book hotels, hotspots, and accommodations. The company was founded in 2022 and is based in Baumkirchen, Austria.

A
American Society of Ketamine Physicians, Psychotherapists, and Practitioners

American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3) is a non-profit healthcare organization. It consists of a group of professionals who direct the safe clinical use of ketamine for mental health disorders and pain conditions. It was founded in 2019 and is based in Bellaire, Texas.

J
Journey Clinical

Journey Clinical develops an online platform intended to assist psychotherapists to grow their practice with psychedelic therapy. The company provides independent licensed mental health and private psychotherapy practitioners with the prescription services they need. It offers ketamine-assisted psychotherapy and integration services. The company was founded in 2020 and is based in New York, New York.

Ember Health Logo
Ember Health

Ember Health provides ketamine therapy for people seeking relief from depression. It works with people managing depression and healthcare professionals seeking services through infusions of medical psychedelic substances, helping patients struggling with mental health issues to establish a personalized, long-term care plan to ensure wellness over time. The company was founded in 2018 and is based in Brooklyn, New York.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.